Platform Diagnostics seeks partners for digital test technology
This article was originally published in Clinica
Executive Summary
Merseyside, UK-based Platform Diagnostics are looking for licensing partners for their unique capillary agglutination technology (CAT), which is currently being implemented as a digital pregnancy test. The success of the test may demonstrate if CAT is suitable for other applications in the worldwide point of care (POC) market.